Empowering Best-In-Class Korean Platform Innovation

Sign Up to Receive Event Updates

Amongst established global biopharma powerhouses like the US and China, how does South Korea carve out its own innovation leadership position?

Through active government investment into AI and in silico capabilities, combined with a uniquely collaborative culture for novelty, as seen through prominent partnerships from companies like 1st Biotherapeutics, Galux, Pharos iBio and SK Biopharmaceuticals, Korea is emerging as a distinct hub for drug discovery excellence to develop differentiated platforms that will deliver best-in-class, impactful breakthroughs.

The World Novel Drug Discovery Summit South Korea is the first and only industry-led forum empowering K-Bio to accelerate innovation and strengthen its position as a globally recognised and competitive drug discovery powerhouse.

Under the theme of accelerating future best-in-class platforms for next-generation modalities by integrating AI for smarter, faster and de-risked drug discovery, this inaugural forum will bring together 100+ K-Bio innovators, international pharma leaders and industry-renowned service providers to dive into cutting-edge technologies, proven drug discovery strategies, and collaborative networking opportunities to empower best-in-class Korean platforms and position K-Bio for global partnering and licensing opportunities.

If you are working in drug discovery, this is where you need to be to generate new insights and connections to enable safer, faster and seamless drug discovery.

Accelerating Future Best-in-Class Platforms for Next-Generation Modalities by Integrating AI for Smarter, Faster & De-Risked Drug Discovery

Download the Agenda

Supported by:

후원:

I am thrilled to participate in the World Drug Discovery Summit South Korea. It is a premier platform to discuss how cutting-edge spatial biology is moving beyond basic research to directly solve critical bottlenecks in drug development.

Daeseung Lee, Co-Founder & Chief Executive Officer, Portrai

I am excited to share my perspectives on using AI and multi-omics data to strengthen target identification and credentialing, uncover disease-relevant biology, and support biomarker programs for clinical decision-making. I also look forward to exchanging practical insights with fellow speakers and attendees on translating AI-enabled multi-omics discoveries into meaningful therapeutic and clinical impact.

Daniel Dai, Scientific Manager, Sanofi

I’m really looking forward to the World Drug Discovery Summit South Korea for the opportunity to identify strategic collaborators in drug discovery who can help us broaden our footprint at the intersection of AI and drug discovery.

Shan Chen, Senior Director, AIDD, Innovent Biologics

I’m looking forward to learning how world-leading companies are leveraging AI in drug discovery, particularly in AI-driven target discovery and drug design in the TPD field.

Chunhui Xu, Lead, AI4Glue Platform, Degron Therapeutics

Expert International & Korean Speaker Faculty:

전문가 연사

Explore the Full Event Guide to Discover:

공식 아젠다를 다운로드하여 다음 내용을 확인하세요

International perspectives to integrate AI/ML technologies to accelerate and enhance drug discovery collaboration opportunities with Eli Lilly, Innovent Bio and Sanofi
Cutting-edge insights to accelerate best-in-class potential platforms from K-Bio trailblazers AIGEN Sciences, Hanmi Pharm, LG Research AI, ONCOCROSS, Portrai and more
Cross-modality case studies with next-generation drug discovery spotlights across ADCs, molecular glues, peptides and cancer vaccines
100+ drug discovery enthusiasts from strategic decision makers to hands-on technical experts across Korean innovators, global pharma leaders and industry-leading service providers
Dedicated structured and spontaneous networking opportunities to foster drug discovery collaborations and partnerships